169 related articles for article (PubMed ID: 38508436)
1. Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine.
Fatehi Hassanabad A; Zarzycki AN; Fedak PWM
Cardiovasc Pathol; 2024; 71():107635. PubMed ID: 38508436
[TBL] [Abstract][Full Text] [Related]
2. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
Morine KJ; Qiao X; York S; Natov PS; Paruchuri V; Zhang Y; Aronovitz MJ; Karas RH; Kapur NK
Circulation; 2018 Jul; 138(5):513-526. PubMed ID: 29487140
[TBL] [Abstract][Full Text] [Related]
3. Cardiac fibroblasts: from development to heart failure.
Moore-Morris T; Guimarães-Camboa N; Yutzey KE; Pucéat M; Evans SM
J Mol Med (Berl); 2015 Aug; 93(8):823-30. PubMed ID: 26169532
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Single-Cell Profiling and Multispecific Therapeutics: Paving the Way for a New Era of Precision Medicine Targeting Cardiac Fibroblasts.
Shi SY; Luo X; Yamawaki TM; Li CM; Ason B; Furtado MB
Curr Cardiol Rep; 2021 Jun; 23(7):82. PubMed ID: 34081224
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of cardiac fibrosis.
Kong P; Christia P; Frangogiannis NG
Cell Mol Life Sci; 2014 Feb; 71(4):549-74. PubMed ID: 23649149
[TBL] [Abstract][Full Text] [Related]
6. Activated Cardiac Fibroblasts Control Contraction of Human Fibrotic Cardiac Microtissues by a β-Adrenoreceptor-Dependent Mechanism.
Błyszczuk P; Zuppinger C; Costa A; Nurzynska D; Di Meglio FD; Stellato M; Agarkova I; Smith GL; Distler O; Kania G
Cells; 2020 May; 9(5):. PubMed ID: 32443848
[TBL] [Abstract][Full Text] [Related]
7. High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy.
McLellan MA; Skelly DA; Dona MSI; Squiers GT; Farrugia GE; Gaynor TL; Cohen CD; Pandey R; Diep H; Vinh A; Rosenthal NA; Pinto AR
Circulation; 2020 Oct; 142(15):1448-1463. PubMed ID: 32795101
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targets for cardiac fibrosis: from old school to next-gen.
Travers JG; Tharp CA; Rubino M; McKinsey TA
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229727
[TBL] [Abstract][Full Text] [Related]
9. NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis.
Fernández-Velasco M; Prieto P; Terrón V; Benito G; Flores JM; Delgado C; Zaragoza C; Lavin B; Gómez-Parrizas M; López-Collazo E; Martín-Sanz P; Boscá L
PLoS One; 2012; 7(9):e45260. PubMed ID: 23028889
[TBL] [Abstract][Full Text] [Related]
10. Role of Cardiac Fibroblasts in Cardiac Injury and Repair.
Han M; Zhou B
Curr Cardiol Rep; 2022 Mar; 24(3):295-304. PubMed ID: 35028821
[TBL] [Abstract][Full Text] [Related]
11. Anti-fibrotic effects of curcumin and some of its analogues in the heart.
Gorabi AM; Hajighasemi S; Kiaie N; Rosano GMC; Sathyapalan T; Al-Rasadi K; Sahebkar A
Heart Fail Rev; 2020 Sep; 25(5):731-743. PubMed ID: 31512150
[TBL] [Abstract][Full Text] [Related]
12. The Alchemist's Nightmare: Might Mesenchymal Stem Cells That Are Recruited to Repair the Injured Heart Be Transformed Into Fibroblasts Rather Than Cardiomyocytes?
Packer M
Circulation; 2018 May; 137(19):2068-2073. PubMed ID: 29735591
[TBL] [Abstract][Full Text] [Related]
13. Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.
Nural-Guvener H; Zakharova L; Feehery L; Sljukic S; Gaballa M
Int J Mol Sci; 2015 May; 16(5):11482-99. PubMed ID: 25997003
[TBL] [Abstract][Full Text] [Related]
14. Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease.
Hall C; Gehmlich K; Denning C; Pavlovic D
J Am Heart Assoc; 2021 Feb; 10(5):e019338. PubMed ID: 33586463
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.
Shih YC; Chen CL; Zhang Y; Mellor RL; Kanter EM; Fang Y; Wang HC; Hung CT; Nong JY; Chen HJ; Lee TH; Tseng YS; Chen CN; Wu CC; Lin SL; Yamada KA; Nerbonne JM; Yang KC
Circ Res; 2018 Apr; 122(8):1052-1068. PubMed ID: 29535165
[TBL] [Abstract][Full Text] [Related]
16. Cortical bone stem cell-derived exosomes' therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling.
Schena GJ; Murray EK; Hildebrand AN; Headrick AL; Yang Y; Koch KA; Kubo H; Eaton D; Johnson J; Berretta R; Mohsin S; Kishore R; McKinsey TA; Elrod JW; Houser SR
Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1014-H1029. PubMed ID: 34623184
[TBL] [Abstract][Full Text] [Related]
17. Stem cell antigen-1
Tao T; Du L; Teng P; Guo Y; Wang X; Hu Y; Zhao H; Xu Q; Ma L
Cell Mol Life Sci; 2023 Sep; 80(10):300. PubMed ID: 37740736
[TBL] [Abstract][Full Text] [Related]
18. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure.
Brown RD; Ambler SK; Mitchell MD; Long CS
Annu Rev Pharmacol Toxicol; 2005; 45():657-87. PubMed ID: 15822192
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Fibrosis: The Fibroblast Awakens.
Travers JG; Kamal FA; Robbins J; Yutzey KE; Blaxall BC
Circ Res; 2016 Mar; 118(6):1021-40. PubMed ID: 26987915
[TBL] [Abstract][Full Text] [Related]
20. Properties and Immune Function of Cardiac Fibroblasts.
Furtado MB; Hasham M
Adv Exp Med Biol; 2017; 1003():35-70. PubMed ID: 28667553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
